IHMA Publications & Posters

Publications Authored by IHMA


  1. Diagnostic Microbiology and Infectious Disease (DMID): Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study
  2. Diagnostic Microbiology and Infectious Disease (DMID): In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002
  3. Diagnostic Microbiology and Infectious Disease (DMID): In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)
  4. Diagnostic Microbiology and Infectious Disease (DMID): In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)
  5. Diagnostic Microbiology and Infectious Disease (DMID): In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)
  6. Diagnostic Microbiology and Infectious Disease (DMID): Antimicrobial susceptibility of extended-spectrum â-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial
  7. International Journal of Antimicrobial Agents (IJAA): Comparative in vitro potency of amoxycillin–clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study
  8. International Journal of Antimicrobial Agents (IJAA): Determining incidence of extended spectrum â-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002
  9. International Journal of Antimicrobial Agents (IJAA): In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study
  10. Journal of Antimicrobial Chemotherapy (JAC): Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin